Health and Fitness Health and Fitness
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009

Hansen Medical, Inc.: Hansen Medical Announces 2009 Second Quarter Conference Call


Published on 2009-07-27 04:09:08, Last Modified on 2009-11-02 11:51:09 - Market Wire
  Print publication without navigation


MOUNTAIN VIEW, CA--(Marketwire - July 27, 2009) - Hansen Medical, Inc. (NASDAQ: [ HNSN ]), the global leader in flexible robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that it will release its financial and operating results for the second quarter ended June 30, 2009 after market close on Tuesday, August 4, 2009.

Hansen Medical will host a conference call at 5:00 p.m. ET (2:00 p.m. PT) on August 4, 2009 to discuss its results. The call may be accessed by dialing 877-941-1468 (480-629-9675 for international callers) and via the Internet in the Investor Relations section of Hansen Medical's website at [ www.hansenmedical.com ]. Please go to the website at least 15 minutes early to register, download and install any necessary audio software. Following the call, a webcast replay will be available on Hansen Medical's website, and an audio replay will also be available by calling 800-406-7325 (303-590-3030 for international callers) and entering the access code 412374. The audio replay will be available through August 18, 2009.

About Hansen Medical, Inc.

Hansen Medical Inc., based in Mountain View, Calif., develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. Its first product, the Sensei™ Robotic Catheter system, is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability during complex cardiac arrhythmia procedures. The Sensei system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data and was cleared by the U.S. Food and Drug Administration (FDA) in May 2007 for manipulation and control of certain mapping catheters in Electrophysiology (EP) procedures. The safety and effectiveness of the Sensei system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei system is cleared for use during EP procedures, such as guiding catheters in the treatment of AF. Additional information can be found at [ www.hansenmedical.com ].

Contributing Sources